LOGIN
Knee osteoarthritis: Plasma rich in growth factor (Endoret) vs. hyaluronic acid (Durolane)
January 2014
Knee osteoarthritis: Plasma rich in growth factor (Endoret) vs. hyaluronic acid (Durolane)
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial
Arthroscopy. 2013 Oct;29(10):1635-43Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
96 patients with osteoarthritis of the knee (OA) were randomized to evaluate the efficacy of 3 injections of plasma rich in growth factors (PRGF-Endoret) against a single injection of Durolane hyaluronic acid (HA) in treating knee OA. Treatments were primarily evaluated based on the percentage of patients having a 30% decrease and a 50% decrease in the summed score for all the Western Ontario and ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.